Pancreatic Cancer Research

ResearcherGunma UniversityNo recent work listed

Tamami Higuchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6049-3666; OpenAlex author ID A5012062566. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models. Co-author DOI 10.1007/s11095-021-03045-5↗
  2. FF-10502, an Antimetabolite with Novel Activity on Dormant Cells, Is Superior to Gemcitabine for Targeting Pancreatic Cancer Cells. Co-author DOI 10.1124/jpet.118.248740↗
  3. Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT-2 pancreatic cancer mous… Co-author DOI 10.3892/ol.2017.7722↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shinji Hagiwara · 2 shared papers, 2018–2021 · strength 0.20
  2. Takeshi Matsumoto · 1 shared paper, 2021 · strength 0.11
  3. Takayuki Asao · 1 shared paper, 2018 · strength 0.09
  4. Takehiko Yokobori · 1 shared paper, 2018 · strength 0.09
  5. Shinji Mima · 1 shared paper, 2018 · strength 0.07
  6. H. Iwamura · 1 shared paper, 2018 · strength 0.07
  7. Yasuhiro Shimada · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.